AppHarmA.com
About AppHarmA.com
A.P. Pharma is a specialty pharmaceutical company developing pharmaceutical products using our proprietary Biochronomer™ polymer-based drug delivery technology. The Company’s primary focus is on its lead product candidate, APF530, which, during 2008, completed a pivotal Phase 3 clinical trial for the prevention of chemotherapy-induced nausea and vomiting (CINV). Results from that trial were announced in the third and fourth quarters of 2008. In July 2009, the U.S.
